Results 61 to 70 of about 9,669 (183)

Silica Nanoparticles as Multifunctional Platforms for Vaccine Delivery and Immune Modulation in Infectious Diseases

open access: yesAdvanced NanoBiomed Research, Volume 5, Issue 12, December 2025.
Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez   +3 more
wiley   +1 more source

Augmentation of IL-21 and soluble CD14 in systemic aspergillosis through combined immunostimulation with beta-glucan and diphtheria toxoid

open access: yesOpen Veterinary Journal
Background: Aspergillus fumigatus leads to serious systemic infections in immunocompromised patients, thereby emphasizing the need for novel immunomodulatory therapies acting on both innate (sCD14) and adaptive (IL-21) immune systems.
Mustafa Abdul Kareem Hameed   +2 more
doaj   +1 more source

mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics

open access: yesCancer Innovation, Volume 4, Issue 6, December 2025.
This review highlights the transformative potential of mRNA cancer vaccines, leveraging technological advancements in nucleotide modification, lipid nanoparticle delivery, and AI‐driven neoantigen selection to enhance vaccine stability, immunogenicity, and personalization.
Bo Yang, Juan Liu, Yang Li, Xiaoxuan Liu
wiley   +1 more source

OBSERVATIONS ON DIPHTHERIA TOXOID AS AN IMMUNIZING AGENT

open access: yesAmerican Journal of Public Health, 1924
water vehicles and has proved to be very economical, easy to perform, reliable and consistent in results, and is adaptable to the testing of materials with organic matter as well as those without. In the examination of materials selective for gram negative organisms, as acriflavine, the colon bacilli can be very properly substituted as a test organism,
W H, Park   +3 more
openaire   +3 more sources

Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBase

open access: yesClinical and Translational Science, Volume 18, Issue 12, December 2025.
ABSTRACT Janus kinase inhibitors (JAKIs) are immunomodulatory drugs used for autoimmune and inflammatory conditions. Their potential impact on pregnancy and fetal development remains a concern due to placental transfer and potential disruption of cytokine and growth factor signaling, with limited human data.
Nazanin Abolhassani   +7 more
wiley   +1 more source

Is Diphtheria Booster Vaccination Still Necessary in Turkey?

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2018
Introduction: Diphtheria is a serious disease that can be prevented by vaccination. The aim of the study was to determine immunity against diphtheria and the necessity of booster doses in the adult population.Materials and Methods: Serum antibody levels ...
Sule Eren CAKAR   +5 more
doaj   +1 more source

Seroprevalence of antibodies against diphtheria, tetanus, and pertussis across various age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand

open access: yesHeliyon
Background: Limited data exists regarding population immunity against diphtheria, tetanus, and pertussis in Thailand during the post-COVID-19 pandemic period. This study aimed to evaluate the age-specific seroprevalence of anti-diphtheria toxoid (anti-DT)
Nasamon Wanlapakorn   +21 more
doaj   +1 more source

Adverse Effects of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine in 6- to 7-Year-Old Children

open access: yesPediatrics and Neonatology, 2011
Although the safety profile of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in adolescents and adults has been documented, few data have reported about their adverse events in children.
Sung-Hsi Wei   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy